Home › NDC Lookup › RxCUI directory › RxCUI 351246

Montelukast 4 MG Oral Granules — RxCUI 351246

RxNorm drug concept · Semantic clinical drug
RxCUI 351246 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 26 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI351246
Official nameMontelukast 4 MG Oral Granules
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmontelukast 4 MG (as montelukast sodium 4.2 MG) Oral Granules; montelukast sodium 4 MG Oral Granules
FDA products mapped13
Package NDCs mapped26
Reported Medicaid activity (SDUD)292,434 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Montelukast: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is used for long-term control of asthma, preventing breathing trouble triggered by exercise, and relieving seasonal and year-round allergy symptoms like a stuffy or runny nose....
  • For asthma, take it once daily in the evening, with or without food. For exercise-triggered symptoms, take it at least 2 hours before exercise. If you have both asthma and allergie...
  • No. Montelukast doesn't reverse an attack, so keep your rescue inhaler handy. You can keep taking montelukast during flare-ups, but use your rescue medicine when symptoms hit.
  • Can I use it for a sudden asthma attack?
📖 Read our full Montelukast guide →

🕸️ Concept Web — How Montelukast 4 MG Oral Granules Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Montelukast 4 MG Oral Granules RxCUI 351246

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Montelukast 88249
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Singulair 153889
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Montelukast Oral Granules 379540
    • Montelukast Granule Product 1295516
    • Montelukast Oral Product 1157311
    • Montelukast Oral Granules [Singulair] 406193
    • Singulair Granule Product 1296002
    • Singulair Oral Product 1183693
    • Oral Granules 317690
    • Granule Product 1294708
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Montelukast 4 MG SCDC · 330865
  • Montelukast Oral Granules SCDF · 379540
  • Montelukast Granule Product SCDG · 1295516
  • Montelukast Oral Product SCDG · 1157311

Brand-Name Concepts

  • Montelukast 4 MG Oral Granules [Singulair] SBD · 404406
  • Montelukast 4 MG [Singulair] SBDC · 542404
  • Montelukast Oral Granules [Singulair] SBDF · 406193
  • Singulair Granule Product SBDG · 1296002
  • Singulair Oral Product SBDG · 1183693
  • Singulair BN · 153889

📦 FDA Products & Package NDCs

13 products · 26 package NDCs
26 package NDCs map to RxCUI 351246 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
13668-0079-05 500 TABLET, CHEWABLE in 1 BOTTLE (13668-079-05) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0079-30 30 TABLET, CHEWABLE in 1 BOTTLE (13668-079-30) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0079-90 90 TABLET, CHEWABLE in 1 BOTTLE (13668-079-90) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0080-05 500 TABLET, CHEWABLE in 1 BOTTLE (13668-080-05) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0080-30 30 TABLET, CHEWABLE in 1 BOTTLE (13668-080-30) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0080-90 90 TABLET, CHEWABLE in 1 BOTTLE (13668-080-90) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0081-05 500 TABLET in 1 BOTTLE (13668-081-05) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0081-30 30 TABLET in 1 BOTTLE (13668-081-30) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0081-32 3200 TABLET in 1 BOTTLE (13668-081-32) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0081-74 100 TABLET in 1 CARTON (13668-081-74) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0081-90 90 TABLET in 1 BOTTLE (13668-081-90) Montelukast Sodium Torrent Pharmaceuticals Limited 2012-08-03
13668-0531-94 30 PACKET in 1 CARTON (13668-531-94) / 500 mg in 1 PACKET (... Montelukast Sodium Torrent Pharmaceuticals Limited 2017-03-30
27241-0015-31 30 GRANULE in 1 CARTON (27241-015-31) MONTELUKAST SODIUM Ajanta Pharma USA Inc. 2015-08-13
27241-0016-03 30 TABLET, CHEWABLE in 1 BOTTLE (27241-016-03) MONTELUKAST SODIUM Ajanta Pharma USA Inc. 2015-08-13
27241-0016-09 90 TABLET, CHEWABLE in 1 BOTTLE (27241-016-09) MONTELUKAST SODIUM Ajanta Pharma USA Inc. 2015-08-13
27241-0017-03 30 TABLET, CHEWABLE in 1 BOTTLE (27241-017-03) MONTELUKAST SODIUM Ajanta Pharma USA Inc. 2015-08-13
27241-0017-09 90 TABLET, CHEWABLE in 1 BOTTLE (27241-017-09) MONTELUKAST SODIUM Ajanta Pharma USA Inc. 2015-08-13
27241-0018-03 30 TABLET, COATED in 1 BOTTLE (27241-018-03) MONTELUKAST SODIUM Ajanta Pharma USA Inc. 2015-08-13
27241-0018-09 90 TABLET, COATED in 1 BOTTLE (27241-018-09) MONTELUKAST SODIUM Ajanta Pharma USA Inc. 2015-08-13
27241-0018-90 1000 TABLET, COATED in 1 BOTTLE (27241-018-90) MONTELUKAST SODIUM Ajanta Pharma USA Inc. 2015-08-13
59651-0329-30 30 PACKET in 1 CARTON (59651-329-30) / 1 GRANULE in 1 PACKE... Montelukast Sodium Aurobindo Pharma Limited 2020-02-18
78206-0170-01 30 TABLET, CHEWABLE in 1 BOTTLE (78206-170-01) SINGULAIR Organon LLC 2021-06-01
78206-0171-01 30 PACKET in 1 CARTON (78206-171-01) / 1 GRANULE in 1 PACKE... SINGULAIR Organon LLC 2021-06-01
78206-0172-01 30 TABLET, FILM COATED in 1 BOTTLE (78206-172-01) SINGULAIR Organon LLC 2021-06-01
78206-0172-02 90 TABLET, FILM COATED in 1 BOTTLE (78206-172-02) SINGULAIR Organon LLC 2021-06-01
78206-0173-01 30 TABLET, CHEWABLE in 1 BOTTLE (78206-173-01) SINGULAIR Organon LLC 2021-06-01
Observed labelers: Torrent Pharmaceuticals Limited (12) · Ajanta Pharma USA Inc. (8) · Organon LLC (5) · Aurobindo Pharma Limited (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.